Herbal Drug Interactions: Investigating Safety and Efficacy in Asian Traditional Medicine
Md Shahadat Hossan 1, Mohammed Rahmatullah 2*, Rownak Jahan 2
Australian Herbal Insight 5(1) 1-8 https://doi.org/10.25163/ahi.5121068
Submitted: 23 January 2022 Revised: 20 February 2022 Published: 20 April 2022
Abstract
Asia and South Asia have long been the centers of traditional medicine in the field of healthcare, with a key role for herbal treatments in recovery and well-being. But as modern pharmaceuticals develop, there's reason for concern about possible drug interactions between herbal remedies and contemporary medications. In order to improve patient safety and treatment efficacy, this abstract highlights the necessity of looking into and comprehending these interactions. Herbal medicine has long been used throughout Asia and South Asia, where it is widely accepted as a standard component of both cultural and medical practices. The natural and comprehensive approach to healing that these herbal treatments are said to provide makes them highly sought after. However, using these herbal remedies in addition to conventional medications raises questions regarding possible interactions that could jeopardize patient safety and therapeutic results. Investigating the complex network of herbal-drug interactions, this review focuses on herbs that are widely utilized in South and Southeast Asia. By examining the effects of these interactions on the effectiveness and safety of traditional medications, the study seeks to clarify the nature of these interactions. The review aims to pinpoint particular herbs and herbal combinations that have either antagonistic or synergistic effects with contemporary medications This information will be crucial for creating treatment programs that minimize risks and optimize therapeutic benefits, eventually enhancing patient safety and wellbeing. Both practitioners of traditional medicine and the contemporary healthcare system should gain from the study's findings, which will support an integrated approach to patient treatment. Healthcare providers can choose the best course of action for their patients by raising understanding about herbal medicine interactions and the possible side effects. This review also describes how to persuade regulatory agencies to create rules and regulations that guarantee the safe coadministration of conventional medications and herbal remedies. To sum up, research on herbal medication interactions in the framework of Asian traditional medicine is essential to improving patient safety and therapeutic effectiveness.
Keywords: Herbal drug interactions, Asian traditional medicine, safety, efficacy, conventional pharmaceuticals, Asia, South Asia.
References
Agrawal, O. P. and Raju, P.S. (2006). Traditional system of medicine. In: Abdin MZ and Abroi YP. (Eds.) Global Market of Herbal Products: Opportunities for India. Narosa Publishing House, New Delhi, India, 5- 10.
Aspden, P., Wolcott, J. A., Bootman, J. L., & Cronenwett, L. R. (Eds.). (2006). Preventing medication errors: Quality chasm series. National Academies Press.
Basnet, P., & Skalko-Basnet, N. (2011). Curcumin: An Anti-Inflammatory Molecule from a Curry Spice on the Path to Cancer Treatment. Molecules, 16(6), 4567-4598.
Bista, D., Palaian, S., Shankar, P. R., Prabhu, M. M., Paudel, R. and Mishra, P. (2006). Understanding the essentials of drug interactions: A potential need for safe and effective use of drugs. Kath. Univ. Med. J. 4 (3), 421-430.
Chan, T. Y. K. (1995). Adverse interactions between warfarin and nonsteroidal anti-inflammatory drugs: mechanisms, clinical significance, and avoidance. Ann. Pharmacother. 29, 1274-83.
Chavez, M. L., Jordan, M. A., Chavez, P. I. (2006). Evidence-based drug–herbal interactions. Life Sciences. 78. 2146–2157
Chopra, R. N., et al. (1956). Indigenous Drugs of India. Academic Publishers.
Christians, U. V. Schmitz and Haschke, M. (2005). Functional interactions between P-glycoprotein and CYP3A in drug metabolism. Expert. Opin. Drug Metab. Toxicol. 1, 641–54.
Cupp, M. J. (1999). Herbal Remedies: adverse effects and drug interactions. Am. Fam. Physician. 59 (5), 1239-45.
Degtyarenko, K. N. (1995). Structural domains of P450-containing monooxygenase systems. Protein Eng. 8 (8), 737-47.
Dewick, P. M. (1997). The biosynthesis of C5–C25 terpenoid compounds. National Productivity Report. 14, 111–144.
Dhar, D., et al. (2015). Ginkgo Biloba: An Important Tool in Treating Neurological and Mental Disorders. Pharmacognosy Reviews, 9(18), 140-145.
Eisenberg, D. M., Davis, R. B. and Ettner, S. L. (1998). Trends in alternative medicine use in the United States, 1990–1997:
Ekor, M. (2013). The Growing Use of Herbal Medicines: Issues Relating to Adverse Reactions and Challenges in Monitoring Safety. Frontiers in Pharmacology, 4, 177.
Epstein, R. M., & Street, R. L. Jr. (2007). Patient-centered communication in cancer care: Promoting healing and reducing suffering. National Cancer Institute, 07-6225.
Ernst, E. (2000). Possible interactions between synthetic and herbal medicinal products. Part 1: a systematic review of the indirect evidence. Perfusion. 13, 2200–2211.
Ernst, E. (2000). Possible interactions between synthetic and herbal medicinal products. Part 1: a systematic review of the indirect evidence. Perfusion. 13, 2200–2211.
Foster Steven and Tyler, V. E. (1999). Tyler's honest herbal: a sensible guide to the use of herbs and related remedies. Xxi, 1999, pp 442.
Garg, A., et al. (2014). Regulatory Requirements for Herbal Drugs in Different Countries. Journal of Chemical and Pharmaceutical Research, 6(8), 389-396.
Glue, P and Clement, R. P. (1999). Cytochrome P450 enzymes and drug metabolism-basic concepts and methods of assessment.Mol. Neurobiol. 19 (3), 309-23.
Greenhalgh, T., Helman, C., & Chowdhury, A. M. (2004). Health beliefs and folk models of diabetes in British Bangladeshis: A qualitative study. BMJ, 318(7185), 463-466.
Grenier, L. (2003). Less interactions medicamenteuses. In: L. Mallet, Grenier, L., Guimond, J., Barbeau, G., eds. Manuel de soins pharmaceutiques en gériatrie. Québec: Presses Del’Université de Laval. 131–52.
Guengerich, F. P. (1997). Role of cytochrome P450 enzymes in drug-drug interactions. Adv. Pharmacol. 43, 7-35.
Guengerich, F. P. (2006). Cytochrome P450s and other enzymes in drug metabolism and toxicity. AAPS. J. 8 (1), E101-11.
Hussain, M. S., Ansari, M. Z. H., Arif, M. (2009). Hyperforin: A lead for Antidepressants. Inter. J. Hea Res. 2(1), 15-22.
Izzo A. A. (2004). Drug interactions with St. John’s wort (Hypericum perforatum): a review of the clinical evidence. Int. J. Clin Pharmacol. Ther. 42, 139–148.
Izzo A. A. (2004). Drug interactions with St. John’s wort (Hypericum perforatum): a review of the clinical evidence. Int. J. Clin. Pharmacol. Ther. 42, 139–148.
Izzo, A. A., et al. (2016). Interactions between Herbs and Conventional Drugs: Overview of the Clinical Data. Medical Principles and Practice, 25(Suppl. 2), 26-46.
Jacobs, B. P., Dennehy, C., Ramirez, G. J., Sapp and Lawrence, V. A. (2002). Milk thistle for the treatment of liver disease: asystematica systematic review and metaanalysis. Amer. J. Med. 113, 506–515.
Jonas, W. B., Levin, J. S., & Taylor, D. S. (2003). Challenging the status quo: Academic integrative medicine centers and the future of primary care. Academic Medicine, 78(10), 1002-1006.
Kaptchuk, T. J. and Eisenberg D. M. (1998). The persuasive appeal of alternative medicine. Ann. Intern. Med. 129, 1061–65.
Kim, M., Yun, S., Lee, Y., & Kim, M. (2019). Traditional herbal medicine Kampo: Evaluation in randomized controlled trials in areas of respiratory system. Evidence-Based Complementary and Alternative Medicine, 2019, 1-11
Lambrecht, J. E., Hamilton W. and Rabinovich A. (2000). A Review of Herb-Drug Interactions: Documented and Theoretical. US Pharmacist. 25 (8), 42-53.
Leape, L. L., Bates, D. W., Cullen, D. J., Cooper, J., Demonaco, H. J., Gallivan, T., ... & Cooper, J. B. (1995). Systems analysis of adverse drug events. JAMA, 274(1), 35-43.
Lee, A and Stockley, I. H. (2003). Drug interactions In Walker R, Edwards C. Clinical Pharmacy and Therapeutics. 3rd ed. Churchill Livingstone, Philadelphia. 21-31.
Linde, K., Ramirez, G., Mulrow, C. D., Pauls, A., Weidenhammer, W. and Melchart D. (1996). St John's wort for depression—an overview and meta-analysis of randomised clinical trials. BM. J. 313, 253–258.
Liu, J., et al. (2016). Traditional Chinese Medicine and the Progress of Modern Medicine: A Challenge for Professional Education. Journal of Chinese Integrative Medicine, 14(4), 241-247.
Marechal1, J. D., Kemp C. A., Roberts, G. C. K., Paine, M. J. I., Wolf, C. R. and Sutcliffe M. J. (2008). Insights into drug metabolism by cytochromes P450 from modelling studies of CYP2D6-drug interactions. B. J. Pharmacol. 153, S82-89.
Meunier, B., De Visser S. P and Shaik S. (2004). Mechanism of oxidation reactions catalyzed by cytochrome P450 enzymes. Chem. Rev. 104, 3947-80.
Munasinghe, T. M. (2002). Adverse drug reactions: monitoring, reporting and prevention. Ceylon. Med. J. 47(1), 19-21.
Munasinghe, T. M. (2002). Adverse drug reactions: monitoring, reporting and prevention. Ceylon. Med. J. 47(1), 19-21.
Muth, C. (2008). Medication safety: How can we learn from errors? Swiss Medical Weekly, 138(47-48), 683-688.
Nathan, P. (1999). The experimental and clinical pharmacology of St John's wort (Hypericum perforatum L.). Mol. Psychiatry. 4, 333–338.
Nebert, D. W. and Russell D. W. (2002). Clinical importance of the cytochromes P450. Lancet. 360, 1155–62.
Nemer, L., et al. (2017). St. John’s Wort Interaction with Voriconazole. Clinical Medicine & Research, 15(1-2), 57-59.
Panda, A. K., et al. (2019). Regulatory Control of Ayurvedic, Siddha, and Unani Drugs in India: A Critical Review. Journal of Traditional and Complementary Medicine, 9(1), 22-31.
Paul, R. and Ortiz, de Montellano (1996). Cytochrome P450: Structure, mechanism and biochemistry. 3rd ed, 35, 4540.
Rastogi, S., et al. (2015). Ayurveda in the Management of Schizophrenia: A Short Review. Indian Journal of Psychiatry, 57(1), 114-116.
Robertson, S. M., Penzak, S. R and Pau, A. K. (2005). Drug interactions in the management of HIV infection. Expert Opin. Pharmacother. 6, 233–53.
Rodriguez-Landa, J. F. and Contreras C. M. (2003). A review of clinical and experimental observations about antidepressant actions and side effects produced by Hypericum perforatum extracts. Phytomedicine. 10, 688–699.
Schultz, V., Hansel, R., and Tyler, V. E. (1998). Rational Phytotherapy: A Physician's Guide to Herbal Medicine. Berlin, Springer-Verlag.
Schulz Volker., Hèansel Rudolf and Tyler, V. E. (2001). Rational phytotherapy: a physician's guide to herbal medicine. Xix, 383pp.
Sharma, A., & Gupta, S. (2018). Therapeutic efficacy of Ayurvedic herbal formulations in the management of type 2 diabetes mellitus: A review. Journal of Ayurveda and Integrative Medicine, 9(4), 310-318.
Shinde, R., et al. (2016). Herbal Remedies and Traditional Medicines in Rural India. Journal of Pharmacognosy and Phytochemistry, 5(4), 55-57.
Smith, M. (2000). Drug interactions with natural health products/dietary supplements: a survival guide. Paper presented at Complementary and Alternative Medicine: Implications for Clinical Practice and State-of-the-Science, Symposia, 2000 March 12, Boston, Mass.
Stewart, M. A. (1995). Effective physician-patient communication and health outcomes: A review. Canadian Medical Association Journal, 152(9), 1423-1433.
Stockley, I. H. (2002). Stockley’s drug interactions, 6th ed. London: pharmaceutical Press.
Street, R. L. Jr., Makoul, G., Arora, N. K., & Epstein, R. M. (2009). How does communication heal? Pathways linking clinician–patient communication to health outcomes. Patient Education and Counseling, 74(3), 295-301.
Verma, J., et al. (2016). Herbal Medicine in the Treatment of Ulcerative Colitis: A Review. International Journal of Pharmaceutical Sciences and Research, 7(12), 4652-4663.
Wagner, H. (1986). Antihepatotoxic flavonoids. Prog in Clin. and Biol. Res. 213, 545–558.
Warrington, J. S. and Shaw L. M. (2005). Pharmacogenetic differences and drug-drug interactions in immunosuppressive therapy Expert Opin. Drug Metab. Toxicol. 1, 487–503.
Werck-Reichhart, D and Feyereisen R. (2000). Cytochromes P450: a success story. 1(6), Reviews 3003.
Wheatley, D. (1997). LI 160, an extract of St. John's wort, versus amitriptyline in mildly to moderately depressed outpatients—a controlled 6-week clinical trial. Pharma. Psychiatry. 30, 77–80.
Wu, J., Liu, B., & Cui, Y. (2017). Clinical and experimental study on the treatment of ulcerative colitis by Bushen Tiaochong Recipe. Chinese Herbal Medicines, 9(4), 360-366.
Xu, X., et al. (2013). Traditional Chinese Medicine in the Chinese Health Care System. Health Policy, 110(2-3), 133-139.
Yun, T. K., & Choi, S. Y. (2013). A Review of Ginseng as a Modifiable Risk Factor for Cancer. The Korean Journal of Internal Medicine, 28(5), 506-516.
Zhang, L., Xu, J., & Huang, Y. (2020). Application of Traditional Chinese Medicine in the Holistic Nursing Care of Patients with Cancer Pain. Pain Management Nursing, 21(6), 625-631.
View Dimensions
View Altmetric
Save
Citation
View
Share